Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bernd Kulzer

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Journal of Diabetes Science and Technology|March 24, 2010
Insulin glargine and incidence of cancer--an ongoing debateNorbert Hermanns, Bernd Kulzer
Journal of Diabetes Science and Technology|August 19, 2024
Connected Pens or Smart Pens: Technology Needs ContextLutz Heinemann, Jochen Sieber, Bernd Kulzer
Journal of Diabetes Science and Technology|May 2, 2023
Evidence and Diabetes Technology: A Catch-22?Norbert Hermanns, Bernd Kulzer, David C Klonoff, et al.
European Endocrinology|June 7, 2018
Freedom of Science - Can Industry Influence What Scientists Publish?Ralph Ziegler, Oliver Schnell, Bernd Kulzer, et al.
Diabetes Care|March 2, 2010
Long-term effect of an education program (HyPOS) on the incidence of severe hypoglycemia in patients with type 1 diabetesNorbert Hermanns, Bernd Kulzer, Michael Krichbaum, et al.
Health and Quality of Life Outcomes|October 6, 2010
Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal studyNorbert Hermanns, Marina Mahr, Bernd Kulzer, et al.
Trials|February 7, 2018
Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trialMelanie Schipfer, Carmen Albrecht, Dominic Ehrmann, et al.
Diabetes Research and Clinical Practice|April 27, 2018
Can trajectories of glycemic control be predicted by depression, anxiety, or diabetes-related distress in a prospective cohort of adults with newly diagnosed type 1 diabetes? Results of a five-year follow-up from the German multicenter diabetes cohort study (GMDC-Study)Hanna Kampling, Oskar Mittag, Stephan Herpertz, et al.
Journal of Diabetes Science and Technology|August 23, 2018
Patch Pumps: Are They All the Same?Lutz Heinemann, Delia Waldenmaier, Bernd Kulzer, et al.
Journal of Diabetes Science and Technology|February 18, 2020
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGMRalph Ziegler, Lutz Heinemann, Guido Freckmann, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Journal of Diabetes Science and Technology|March 24, 2010
Insulin glargine and incidence of cancer--an ongoing debateNorbert Hermanns, Bernd Kulzer
Journal of Diabetes Science and Technology|August 19, 2024
Connected Pens or Smart Pens: Technology Needs ContextLutz Heinemann, Jochen Sieber, Bernd Kulzer
Journal of Diabetes Science and Technology|May 2, 2023
Evidence and Diabetes Technology: A Catch-22?Norbert Hermanns, Bernd Kulzer, David C Klonoff, et al.
European Endocrinology|June 7, 2018
Freedom of Science - Can Industry Influence What Scientists Publish?Ralph Ziegler, Oliver Schnell, Bernd Kulzer, et al.
Diabetes Care|March 2, 2010
Long-term effect of an education program (HyPOS) on the incidence of severe hypoglycemia in patients with type 1 diabetesNorbert Hermanns, Bernd Kulzer, Michael Krichbaum, et al.
Health and Quality of Life Outcomes|October 6, 2010
Barriers towards insulin therapy in type 2 diabetic patients: results of an observational longitudinal studyNorbert Hermanns, Marina Mahr, Bernd Kulzer, et al.
Trials|February 7, 2018
Makes FLASH the difference between the intervention group and the treatment-as-usual group in an evaluation study of a structured education and treatment programme for flash glucose monitoring devices in people with diabetes on intensive insulin therapy: study protocol for a randomised controlled trialMelanie Schipfer, Carmen Albrecht, Dominic Ehrmann, et al.
Diabetes Research and Clinical Practice|April 27, 2018
Can trajectories of glycemic control be predicted by depression, anxiety, or diabetes-related distress in a prospective cohort of adults with newly diagnosed type 1 diabetes? Results of a five-year follow-up from the German multicenter diabetes cohort study (GMDC-Study)Hanna Kampling, Oskar Mittag, Stephan Herpertz, et al.
Journal of Diabetes Science and Technology|August 23, 2018
Patch Pumps: Are They All the Same?Lutz Heinemann, Delia Waldenmaier, Bernd Kulzer, et al.
Journal of Diabetes Science and Technology|February 18, 2020
Intermittent Use of Continuous Glucose Monitoring: Expanding the Clinical Value of CGMRalph Ziegler, Lutz Heinemann, Guido Freckmann, et al.
Pageof 3